No Data
No Data
J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Announce Winner of Inaugural 2024 Life Sciences Innovation Summit
In conjunction with Abu Dhabi Global Healthcare Week 2024 ABU DHABI, UAE, May 17, 2024 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Group annou
Buy Rating Affirmed for Harmonic: Strong Customer Upgrades and Sustainable Growth Outlook
Express News | Needham Reiterates Buy on Harmonic, Maintains $18 Price Target
Harmonic Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/17/2024 54.24% Needham → $18 Reiterates Buy → Buy 04/30/2024 54.24% Needham → $18 Reiterates Buy → Buy
Third Harmonic Bio, Inc.: Positive Outlook on THB335's Clinical Advancements and Strategic Developments
Express News | Third Harmonic Bio Inc : Jefferies Raises Target Price to $15 From $8.1